EGFR and small cell lung carcinoma: Because EPCAM-based CTC enrichment is validated for the detection of small-cell lung cancer with comparable biology, we argue that EPCAM-based enrichment provides relevant information about the CTC subpopulation with NE traits, especially when combined with enrichment for EGFR and HER2 as in the AdnaTest [19, 21–24].